Ventas Sees 9.9% FFO Rise, Projects Up to 17% NOI
Ventas reported fourth-quarter 2025 normalized FFO of $0.89 per share, a 9.9% year-over-year increase, as same-store cash NOI rose on strong senior housing and outpatient medical performance. It forecasts 2026 same-store cash NOI growth of 13–17% in its senior housing portfolio and 2–3% in its medical and research portfolio.
1. Six-Month Performance and Q4 Results
Ventas shares rose 24.8% over six months as fourth-quarter 2025 normalized FFO reached $0.89 per share, reflecting a 9.9% increase year over year on rising same-store cash NOI driven by senior housing and outpatient medical operations.
2. Segment Performance and 2026 Guidance
The senior housing operating portfolio generated 15.4% same-store cash NOI growth in Q4 and is forecast to grow 13–17% in 2026, while the outpatient medical and research portfolio posted 3.7% growth with guidance of 2–3% for the year ahead.
3. Balance Sheet Strength and Capital Recycling
The company ended 2025 with $5.3 billion of liquidity and improved net debt to EBITDA from 6.0X to 5.2X, selling $223.2 million of non-core assets and acquiring $2.3 billion in senior housing communities to optimize its portfolio.
4. Competitive and Financial Risks
Competition in senior housing limits rent increases and occupancy power, and a total debt load of $12.65 billion may sustain elevated interest expenses, posing challenges to profitability and future balance sheet flexibility.